Number of the records: 1
fingolimod hydrochlorid
SYS d000068876 LBL 00000cz--a2200181n--4500 005 20250606221740.1 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 $d BA006 065 $a D02.033.100.700.350 065 $a D02.033.455.706.431 065 $a D02.092.063.700.350 066 $a 01 $c 03 150 $a fingolimod hydrochlorid $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a fingolimodi hydrochloridum $2 slo 450 $w v $a FTY 720 $2 slo 450 $w v $a fingolimod $2 slo 550 $7 sllk_us_auth*d007166 $Y Immunosuppressive Agents $w P $a imunosupresíva 550 $7 sllk_us_auth*d000081243 $Y Sphingosine 1 Phosphate Receptor Modulators $w P $a modulátory receptora sfingozín-1-fosfátu 665 $a 2016 (1996) $2 eng 680 9-
$i A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS. $2 eng 750 -2
$a Fingolimod Hydrochloride $2 eng 980 $x M
Number of the records: 1